| Pharmaceutical Information |
| Drug Name |
Dichlorphenamide |
| Drug ID |
BADD_D00652 |
| Description |
A carbonic anhydrase inhibitor that is used in the treatment of glaucoma. |
| Indications and Usage |
For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure |
| Marketing Status |
approved; investigational |
| ATC Code |
S01EC02 |
| DrugBank ID |
DB01144
|
| KEGG ID |
D00518
|
| MeSH ID |
D004005
|
| PubChem ID |
3038
|
| TTD Drug ID |
D0J4GO
|
| NDC Product Code |
72065-002; 59651-223; 13668-676; 71090-001; 73435-011; 72065-001; 58159-071 |
| UNII |
VVJ6673MHY
|
| Synonyms |
Dichlorphenamide | Dichlofenamide | Diclofenamid | Glauconide | Daranide |
|
| Chemical Information |
| Molecular Formula |
C6H6Cl2N2O4S2 |
| CAS Registry Number |
120-97-8 |
| SMILES |
C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
